Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mucus secretion is the process by which specialized cells, primarily goblet cells and submucosal glands, produce and release mucus—a gel-like substance composed mainly of water and mucins. This process is essential for protecting epithelial surfaces, trapping pathogens and debris, and maintaining tissue hydration. Mucus secretion is regulated by neural and inflammatory signals. Dysregulation of mucus secretion contributes to various respiratory and gastrointestinal diseases, including asthma, COPD, cystic fibrosis, ulcerative colitis and Crohn's disease.
Mucolytics: Break down mucus structure. Bronchodilators: Reduce airway constriction, facilitating mucus clearance. Anti-inflammatory drugs: Reduce inflammation and mucus hypersecretion.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mucus Secretion.